Skip to main content
VulnerabilityPublished

CVE-2026-7702: toeverything AFFiNE · Improper Authorization

Source GCVE Database

0
Authoritative record:CVE-2026-7702· Medium 6.9

Public exploit available · CVSS 6.9 Medium.

Data as of 27 Oct 2026, 01:05 UTC

CVSS 4.0 base score
6.9Medium
How severe the flaw is on the 0–10 CVSS scale.
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 3 May 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: evidence found.

    CVSS exploit maturity: proof of concept public

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), CVSS vector, the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
toeverythingAFFiNEAffected
  • 0.26.0 – 0.26.3
4 affected builds
Fixed in–
GitHubtoeverything/AFFiNEpkg:github/toeverything/AFFiNEOther threatsAffected
  • 0.26.0 – 0.26.3
4 affected builds
Fixed in–

Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.

AI-suggested

Users should apply strict access controls around the affected endpoint if possible and monitor for any updates from the vendor. Consider restricting public access to the markdown preview feature until a fix is released.

Description

A vulnerability in toeverything AFFiNE up to version 0.26.3 allows remote attackers to bypass authorization via the allowDocPreview function in the Public Markdown Preview Endpoint. The issue enables unauthorized access to document previews without proper permissions. Public exploit code is available, and the vendor has not responded to the disclosure.

References

Community reviews

Loading reviews…